IP Library Granted Patent US 12,343,511
Granted Patent B1
US 12,343,511 · App. 18/640,427 · Granted Jul 1, 2025

Medicament delivery device

Inventors: Alexander Hee-Hanson (Melbourn, GB); Michael Parrott (Melbourn, GB); Nicholas Harding (Melbourn, GB); Robert Wilson (Melbourn, GB); Thomas Lever (Melbourn, GB)
Assignee: Genzyme Corporation
A61M5/31566A61M5/3243A61M2005/2073A61M2005/208
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,343,511
App. No.
18/640,427
Granted
Jul 1, 2025
Kind
B1
Abstract

A medicament delivery device includes an actuator including an actuation member configured to be movable by a user to an actuation position to cause a dose of medicament to be dispensed from the medicament delivery device. The actuator is configured to be movable from a deactivated position in which a user is prevented from moving the actuation member to the actuation position to an activated position in which the actuation member is released for movement by a user to the actuation position. The device includes a temperature-dependent actuator configured to move the actuator from the deactivated position to the activated position in response to a change in temperature of the temperature-dependent actuator.

Claims (42)

1. A medicament delivery device comprising:

an actuator comprising a needle sleeve configured to be movable by a user to an actuation position to cause a dose of medicament to be dispensed from the medicament delivery device, the actuator being configured to be movable from (i) a deactivated position in which the user is prevented from moving the needle sleeve to the actuation position to (ii) an activated position in which the needle sleeve is released for movement by the user to the actuation position; and

a temperature-dependent actuator configured to move the actuator from the deactivated position to the activated position in response to a change in temperature of the temperature-dependent actuator.

2. The medicament delivery device of claim 1 , wherein the temperature-dependent actuator comprises a bimetallic strip to cause the actuator to rotate from the deactivated position to the activated position in response to the change in temperature of the temperature-dependent actuator.

3. The medicament delivery device of claim 1 , wherein the temperature-dependent actuator comprises a phase change actuator comprising a phase change material configured to change phase in response to the change in temperature of the temperature-dependent actuator.

4. The medicament delivery device of claim 1 , wherein the medicament delivery device comprises a container for containing medicament.

5. The medicament delivery device of claim 4 , wherein the container is a syringe comprising a needle and containing the dose of medicament.

6. A medicament delivery device comprising:

a body configured to hold a medicament container;

a member configured to rotate relative to the body from (i) a first rotational position in which axial movement of the member relative to the body is limited to (ii) a second rotational position in which axial movement of the member is allowed; and

a temperature-dependent actuator configured to rotate the member from the first rotational position to the second rotational position,

wherein the medicament delivery device is configured such that when the member is in the second rotational position, the member is axially movable relative to the body along a longitudinal axis of the body to cause a medicament to be dispensed from the medicament container.

7. The medicament delivery device of claim 6 , wherein the member comprises a button configured to move between (i) a distal position in which a proximal end of the member extends proximally beyond a proximal end of the body by a first distance and (ii) a proximal position in which the proximal end of the member extends proximally beyond the proximal end of the body by a second distance that is greater than the first distance.

8. The medicament delivery device of claim 7 , wherein the medicament delivery device is configured such that when the member is in the second rotational position, the member is movable from the proximal position to the distal position to cause the medicament to be dispensed from the medicament container.

9. The medicament delivery device of claim 6 , wherein the member comprises a needle sleeve configured to move between (i) a distal position in which a distal end of the member is distal to a distal end of a needle attached to the medicament container and (ii) a proximal position in which the distal end of the needle is distal to the distal end of the member.

10. The medicament delivery device of claim 9 , wherein the medicament delivery device is configured such that when the member is in the second rotational position, the member is movable from the distal position to the proximal position to cause the medicament to be dispensed from the medicament container.

11. The medicament delivery device of claim 6 , wherein the member is configured to rotate from the first rotational position to the second rotational position without user assistance.

12. A medicament delivery device comprising:

an actuator comprising an actuation member configured to be movable to an actuation position to cause a dose of medicament to be dispensed from the medicament delivery device, the actuator being configured to be movable from (i) a deactivated position in which a movement of the actuation member to the actuation position is limited to (ii) a raised position in which the actuation member is rotatable to a depressible position for allowing the movement of the actuation member to the actuation position; and

a temperature-dependent actuator configured to move the actuator from the deactivated position to the raised position in response to a change in temperature of the temperature-dependent actuator.

13. The medicament delivery device of claim 12 , wherein the actuation member comprises a button configured to be depressible by a user to the actuation position.

14. The medicament delivery device of claim 12 , wherein the temperature-dependent actuator comprises a piston slidably received within a cylinder.

15. The medicament delivery device of claim 12 , wherein the temperature-dependent actuator comprises a phase change actuator comprising a phase change material configured to change phase in response to the change in temperature of the temperature-dependent actuator.

16. The medicament delivery device of claim 12 , wherein the medicament delivery device comprises a container for containing medicament.

17. The medicament delivery device of claim 16 , wherein the container is a syringe comprising a needle and containing the dose of medicament.

18. A medicament delivery device comprising:

an actuator comprising an actuation member configured to be movable by a user to an actuation position to cause a dose of medicament to be dispensed from the medicament delivery device, the actuator being configured to be movable from (i) a deactivated position in which the user is prevented from moving the actuation member to the actuation position to (ii) a raised position in which the actuation member is rotatable to a depressible position for allowing movement by the user to the actuation position; and

a temperature-dependent actuator configured to move the actuator from the deactivated position to the raised position in response to a change in temperature of the temperature-dependent actuator.

19. The medicament delivery device of claim 18 , wherein the actuation member comprises a button configured to be depressible by the user to the actuation position.

20. The medicament delivery device of claim 18 , wherein the temperature-dependent actuator comprises a piston slidably received within a cylinder.

21. The medicament delivery device of claim 18 , wherein the temperature-dependent actuator comprises a phase change actuator comprising a phase change material configured to change phase in response to the change in temperature of the temperature-dependent actuator.

22. The medicament delivery device of claim 21 , wherein the actuation member comprises a drive slot and the temperature-dependent actuator comprises a protrusion slidably received within the drive slot for constraining movement of the protrusion with respect to the drive slot.

23. The medicament delivery device of claim 22 , wherein the drive slot comprises a circumferentially-extending portion and a first axially-extending portion such that, when the actuator is in the deactivated position, the protrusion is received within the circumferentially-extending portion of the drive slot such that the temperature-dependent actuator causes the actuation member to move to the raised position in response to the temperature change of the temperature-dependent actuator.

24. The medicament delivery device of claim 23 , wherein the medicament delivery device is configured such that moving the actuation member to the raised position allows the actuation member to rotate to the depressible position to thereby cause the protrusion to enter the first axially-extending portion of the drive slot, thereby allowing the actuation member to be depressed by the user from the depressible position to the actuation position.

25. The medicament delivery device of claim 24 , wherein the circumferentially-extending portion of the drive slot has an axially-extending component of direction for translating axial movement of the protrusion into rotation of the actuation member to cause the actuation member to rotate to the depressible position.

26. The medicament delivery device of claim 25 , wherein:

the actuation member comprises a guide slot comprising an axially-extending portion, and

the medicament delivery device comprises a guide protrusion fixed relative to a body of the medicament delivery device, the guide protrusion located in the guide slot for limiting movement of the actuation member relative to the body.

27. The medicament delivery device of claim 26 , wherein the medicament delivery device is configured such that when the protrusion is received within the circumferentially-extending portion of the drive slot, the guide protrusion is located in the axially-extending portion of the guide slot for allowing the actuation member to move axially relative to the body as the temperature-dependent actuator moves the actuator from the deactivated position to the raised position.

28. The medicament delivery device of claim 26 , wherein the guide slot comprises a circumferentially-extending portion for permitting rotation of the actuation member, the circumferentially-extending portion of the guide slot having a first end connected to the axially-extending portion of the guide slot.

29. The medicament delivery device of claim 28 , wherein the medicament delivery device is configured such that when the temperature-dependent actuator moves the actuator from the deactivated position to the raised position, the guide protrusion is caused to travel from the axially-extending portion of the guide slot along the circumferentially-extending portion of the guide slot so as to cause the actuation member to rotate as the actuation member moves to the raised position.

30. The medicament delivery device of claim 18 , wherein the medicament delivery device comprises a container containing the dose of medicament.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: HEE-HANSON, ALEXANDER; LEVER, THOMAS; PARROTT, MICHAEL; WILSON, ROBERT; HARDING, NICHOLAS OLIVER
To: PA HOLDINGS LIMITED
Reel/Frame 070396/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: PA HOLDINGS LIMITED
To: PA CONSULTING SERVICES LIMITED
Reel/Frame 070396/0735 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: PA CONSULTING SERVICES LIMITED
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 070396/0785 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: SANOFI-AVENTIS DEUTSCHLAND GMBH
To: GENZYME CORPORATION
Reel/Frame 070396/0814 →
References Cited (94)
US 2522961A · William · 1950 [cited by applicant]
US 2633267A · Lebus · 1953 [cited by applicant]
US 3886513A · Smith · 1975 [cited by examiner]
US 4801295A · Spencer · 1989 [cited by applicant]
US 5045062A · Henson · 1991 [cited by applicant]
US 5176275A · Bowie · 1993 [cited by applicant]
US 5328484A · Somers et al. · 1994 [cited by applicant]
US 5396051A · Kuhn et al. · 1995 [cited by applicant]
US 5478316A · Bitdinger et al. · 1995 [cited by applicant]
US 5505324A · Danico · 1996 [cited by applicant]
US 5505706A · Maus et al. · 1996 [cited by applicant]
US 5536917A · Suppelsa et al. · 1996 [cited by applicant]
US 5622274A · Bright · 1997 [cited by applicant]
US 5738658A · Maus et al. · 1998 [cited by applicant]
US 5984899A · D'Alessio et al. · 1999 [cited by applicant]
US 6080461A · Wozniak et al. · 2000 [cited by applicant]
US 6394985B1 · Lin · 2002 [cited by applicant]
US 7762981B2 · Dacquay et al. · 2010 [cited by applicant]
US 7887506B1 · Smolyarov et al. · 2011 [cited by applicant]
US 7918824B2 · Bishop et al. · 2011 [cited by applicant]
US 8133198B2 · Neer · 2012 [cited by applicant]
US 8409138B2 · James et al. · 2013 [cited by applicant]
US 8734394B2 · Adams et al. · 2014 [cited by applicant]
US 9044553B2 · James et al. · 2015 [cited by applicant]
US 9402957B2 · Adams et al. · 2016 [cited by applicant]
US 9872961B2 · Fourt et al. · 2018 [cited by applicant]
US 10118001B2 · Fourt et al. · 2018 [cited by applicant]
US 10314981B2 · Sampson et al. · 2019 [cited by applicant]
US 10350362B2 · Dennis, Jr. et al. · 2019 [cited by applicant]
US 10363377B2 · Atterbury et al. · 2019 [cited by applicant]
US 11298462B2 · Atterbury et al. · 2022 [cited by applicant]
US 11331432B2 · Holmqvist et al. · 2022 [cited by applicant]
US 11369751B2 · Ruan et al. · 2022 [cited by applicant]
US 11452821B2 · LaFever et al. · 2022 [cited by applicant]
US 20020055712A1 · Neracher · 2002 [cited by applicant]
US 20040039336A1 · Amark et al. · 2004 [cited by applicant]
US 20050101919A1 · Brunnberg · 2005 [cited by applicant]
US 20050273061A1 · Hommann et al. · 2005 [cited by applicant]
US 20060224124A1 · Scherer · 2006 [cited by applicant]
US 20070270777A1 · Dacquay et al. · 2007 [cited by applicant]
US 20080097311A1 · Dacquay et al. · 2008 [cited by applicant]
US 20080097390A1 · Dacquay et al. · 2008 [cited by applicant]
US 20080269692A1 · James et al. · 2008 [cited by applicant]
US 20090036868A1 · Pinedjian et al. · 2009 [cited by applicant]
US 20090281496A1 · Matusch · 2009 [cited by applicant]
US 20100211005A1 · Edwards et al. · 2010 [cited by applicant]
US 20110054414A1 · Shang et al. · 2011 [cited by applicant]
US 20110144594A1 · Sund et al. · 2011 [cited by applicant]
US 20110202011A1 · Wozencroft · 2011 [cited by applicant]
US 20110319813A1 · Kamen et al. · 2011 [cited by applicant]
US 20130237921A1 · Lannan et al. · 2013 [cited by applicant]
US 20130267897A1 · Kemp et al. · 2013 [cited by applicant]
US 20140236076A1 · Marshall et al. · 2014 [cited by applicant]
US 20140249483A1 · Kiilerich et al. · 2014 [cited by applicant]
US 20140263156A1 · Newsom et al. · 2014 [cited by applicant]
US 20140276637A1 · Massey, Jr. · 2014 [cited by applicant]
US 20150246180A1 · Fenlon · 2015 [cited by examiner]
US 20150273162A1 · Holmqvist · 2015 [cited by applicant]
US 20160001015A1 · Kucuk et al. · 2016 [cited by applicant]
US 20160354555A1 · Gibson · 2016 [cited by examiner]
US 20160367763A1 · Tschirren et al. · 2016 [cited by applicant]
US 20170215699A1 · Ouyang et al. · 2017 [cited by applicant]
US 20170216526A1 · Brereton et al. · 2017 [cited by applicant]
US 20170224929A1 · Sampson et al. · 2017 [cited by applicant]
US 20170246403A1 · Cowe et al. · 2017 [cited by applicant]
US 20170361034A1 · Scheller et al. · 2017 [cited by applicant]
US 20180250471A1 · Grimoldby et al. · 2018 [cited by applicant]
US 20180339114A1 · Wendland et al. · 2018 [cited by applicant]
US 20190030249A1 · Gonzalez et al. · 2019 [cited by applicant]
US 20190192785A1 · Wendland et al. · 2019 [cited by applicant]
US 20190366000A1 · Cowe et al. · 2019 [cited by applicant]
US 20200114041A1 · Alas et al. · 2020 [cited by applicant]
US 20200316314A1 · Buri et al. · 2020 [cited by applicant]
US 20210077732A1 · Egelhofer · 2021 [cited by applicant]
US 20210196900A1 · Apply et al. · 2021 [cited by applicant]
US 20220015429A1 · Brown · 2022 [cited by examiner]
US 20220176042A1 · Belisle · 2022 [cited by applicant]
US 20220395640A1 · Schwartzentruber · 2022 [cited by applicant]
US 20230001099A1 · Dunn · 2023 [cited by applicant]
US 20230238105A1 · Schneider et al. · 2023 [cited by applicant]
US 20230347074A1 · Gavin · 2023 [cited by applicant]
US 20240009397A1 · In et al. · 2024 [cited by applicant]
DE 3921747A1 · 1991 [cited by applicant]
EP 3501577A1 · 2019 [cited by applicant]
WO WO2002047746A1 · 2002 [cited by applicant]
WO WO2011109205A2 · 2011 [cited by applicant]
WO WO2016081238A1 · 2016 [cited by applicant]
WO WO2019074788A1 · 2019 [cited by applicant]
WO WO2020190529A1 · 2020 [cited by applicant]
Needle-based injection systems for medical use requirements and test methods, Part 1: Needle injection systems, ISO 11608-1:2014(E), Third Edition, Switzerland, ISO, Dec. 15, 2014, pp. 1-13. [cited by applicant]
U.S. Appl. No. 18/640,163, filed Apr. 19, 2024, Alexander Hee-Hanson. [cited by applicant]
U.S. Appl. No. 18/640,292, filed Apr. 19, 2024, Alexander Hee-Hanson. [cited by applicant]
U.S. Appl. No. 18/640,600, filed Apr. 19, 2024, Alexander Hee-Hanson. [cited by applicant]
U.S. Appl. No. 18/640,710, filed Apr. 19, 2024, Alexander Hee-Hanson. [cited by applicant]